Galimedix Therapeutics has announced the initiation of a phase 2 clinical study called eDREAM (NCT06...

Glaukos Corporation has officially submitted a New Drug Application (NDA) to the U.S. Food and Drug ...

4D Molecular Therapeutics (4DMT) has announced the publication of preclinical data underscoring the ...

Sepul Bio has announced the dosing of the first patient in the LUNA clinical study, a Phase 2b trial...

Opus Genetics has announced a key regulatory milestone, securing a Special Protocol Assessment (SPA)...

Regeneron Pharmaceuticals has announced that its Phase 3 QUASAR trial evaluating EYLEA HD (afliberce...

Aurion Biotech has released topline data from its Phase 1/2 clinical trial (CLARA), evaluating AURN0...

FDA has cleared the investigational new drug (IND) application for VG801, ViGeneron’s novel gene the...

Viridian Therapeutics has announced positive topline results from the Phase 3 THRIVE-2 clinical tria...

The European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued...